Please assess the completion status of the following clinical trial:

Trial Title: Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 1-3 years~* Fever = or \> 38.0 C and at least one respiratory symptom OR fever = or \> 38.0 C and a positive influenza rapid test~Exclusion Criteria:~* Confirmed infection with any other respiratory virus than influenza.~* Suspicion of invasive bacterial infection requiring immediate admission to hospital~* Evidence of a poorly controlled underlying medical condition~* Known immunosuppression (malignancy, transplant, drugs)~* Known allergy to oseltamivir or paracetamol~* Received oseltamivir within 4 weeks~* Participation in another clinical trial with an investigational drug

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 3 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Oseltamivir
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).